Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer
Clinical trial NCT00909025 · COMPLETED
Trial details
- NCT number
- NCT00909025
- Sponsor
- Ganymed Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-31
- Primary completion
- 2010-05-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.